Amphiregulin couples IL1RL1 + regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity
Science Advances · 25.08.2023 · 9 (34)
DOI: 10.1126/sciadv.add7399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 25.08.2023. Verfasst von Runzi Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NLM NIH HHS.
Abstract (Originalsprache)
Regulatory T (T reg ) cells and cancer-associated fibroblasts (CAFs) jointly promote tumor immune tolerance and tumorigenesis. The molecular apparatus that drives T reg cell and CAF coordination in the tumor microenvironment (TME) remains elusive. Interleukin 33 (IL-33) has been shown to enhance fibrosis and IL1RL1 + T reg cell accumulation during tumorigenesis and tissue repair. We demonstrated that IL1RL1 signaling in T reg cells greatly dampened the antitumor activity of both IL-33 and PD-1 blockade. Whole tumor single-cell RNA sequencing (scRNA-seq) analysis and blockade experiments revealed that the amphiregulin (AREG)–epidermal growth factor receptor (EGFR) axis mediated cross-talk between IL1RL1 + T reg cells and CAFs. We further demonstrated that the AREG/EGFR axis enables T reg cells to promote a profibrotic and immunosuppressive functional state of CAFs. Moreover, AREG mAbs and IL-33 concertedly inhibited tumor growth. Our study reveals a previously unidentified AREG/EGFR-mediated T reg /CAF coupling that controls the bifurcation of fibroblast functional states and is a critical barrier for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA.
- Department of Biomedical informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- Department of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
ORCID-Profile: Runzi Sun, David Shihong Gao, Andrew Ni, Haochen Li, Xinghua Lu, Binfeng Lu
Förderung
- NCI NIH HHS
- NLM NIH HHS
Zitieren
APA
Sun, R., Zhao, H., Gao, D. S., Ni, A., Li, H., Chen, L., Lu, X., Chen, K., & Lu, B. (2023). Amphiregulin couples IL1RL1 + regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity. Science Advances, 9(34). https://doi.org/10.1126/sciadv.add7399
Vancouver
Sun R, Zhao H, Gao DS, Ni A, Li H, Chen L, et al. Amphiregulin couples IL1RL1 + regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity. Science Advances. 2023;9(34). doi:10.1126/sciadv.add7399
BibTeX
@article{Sun2023,
author = {Sun, Runzi and Zhao, Hongyu and Gao, David Shihong and Ni, Andrew and Li, Haochen and Chen, Lujia and Lu, Xinghua and Chen, Kong and Lu, Binfeng},
title = {Amphiregulin couples IL1RL1 + regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {34},
doi = {10.1126/sciadv.add7399}
}
EUVIMED